Drug Plan Coverage Denied in Canada: Appeal Guide

Prescription drug coverage in Canada is a patchwork system: provincial drug plans cover some residents for some drugs, employer group benefit plans fill gaps for working Canadians, and an estimated 10% of Canadians have no drug coverage at all. When your drug plan denies coverage for a medication your doctor has prescribed, you have real options for appeal — at both the provincial and private insurer level.

Canada's Drug Coverage Landscape

Provincial drug plans cover specific eligible populations and maintain formularies (approved drug lists) of covered medications. The main provincial plans are:

• Ontario Drug Benefit (ODB) — covers seniors (65+), Ontario Works and ODSP recipients, and residents of long-term care homes. Ontario's Trillium Drug Program covers those with high drug costs relative to income.
• BC PharmaCare — multiple plans covering seniors, low-income residents, and people with high drug costs (Fair PharmaCare).
• Quebec's RAMQ (Régie de l'assurance maladie du Québec) — Quebec has a unique universal drug insurance regime. Most Quebec residents must be covered either by a private group plan (through their employer) or by the RAMQ public plan. This quasi-mandatory coverage means drug denials involve both private insurers and RAMQ.
• Alberta Drug Benefit Program — covers Alberta Seniors Benefit, AISH, and certain other eligible groups.
• Other provincial plans — all provinces have some form of drug coverage for specific populations.

Employer group plans cover prescription drugs for most working Canadians through insured benefit plans with Sun Life, Manulife, Canada Life, Desjardins, Green Shield Canada, and Blue Cross plans.

Why Drug Claims Are Denied

Drug not on the formulary. Each provincial plan and each employer group plan has its own formulary. A drug approved by Health Canada (meaning it is safe and effective for sale in Canada) may not be on a specific formulary. Formulary status depends on cost-effectiveness evaluations, often conducted by CADTH (Canadian Drug and Health Technology) for federal and provincial programs.

Special authorization required. Many drugs are on the formulary but require special authorization — a process where your physician submits evidence that you meet specific clinical criteria for the drug. Common examples include biologic medications for rheumatoid arthritis, Crohn's disease, psoriasis, and multiple sclerosis; certain oncology drugs; and high-cost specialty medications. If your physician did not submit a special authorization form, the claim will be denied.

Exception drug status. Under programs like Ontario's ODB, drugs that are not on the formulary can sometimes be funded through an "exceptional access" or "Section 8" process. Your physician must submit a written request to the provincial program demonstrating exceptional clinical circumstances.

Annual maximum reached (employer plans). Many employer drug plans have an annual maximum for drug coverage. This is less common than annual dental limits but exists in some plans, particularly for high-cost specialty drugs.

Drug is excluded from the plan. Some drugs are specifically excluded regardless of formulary status — lifestyle drugs, experimental therapies, or drugs available over the counter without a prescription may be excluded.

Incorrect drug identification or billing error. Drug claims run through electronic adjudication systems. The DIN (Drug Identification Number) submitted by your pharmacy must match the plan's records. Errors at the pharmacy level can cause automatic denials.

Appealing a Provincial Drug Plan Denial

Ontario ODB Special Authorization. If a drug requires special authorization under ODB and was denied, your physician can submit a Special Authorization form to Ontario Drug Programs. If the initial application is denied, physicians can request a review or submit additional clinical evidence.

Ontario Exceptional Access Program (Section 8). For drugs not on the ODB formulary, physicians can submit a Section 8 request to Ontario Drug Programs. This process allows coverage of specific drugs for specific patients in exceptional circumstances.

BC PharmaCare Special Authority. BC PharmaCare's Special Authority program works similarly to ODB Special Authorization. Your physician submits a Special Authority request; PharmaCare assesses the clinical evidence. Denied requests can be reviewed.

RAMQ Quebec appeals. RAMQ has an internal review process for denial decisions. Physicians and patients can request reconsideration with additional clinical evidence. For persistent disputes, the Commission des droits de la personne et des droits de la jeunesse (CDPDJ) and the Protecteur du citoyen (Quebec Ombudsman) can assist.

Other provinces. Each provincial drug plan has its own appeal mechanism. Contact your provincial health authority for the specific process.

Appealing an Employer Group Plan Drug Denial

Internal appeal. Write to your insurer's group benefits claims team. Include:

• The specific drug name, DIN, and dispensing date.
• Your physician's prescription and clinical notes.
• A letter from your physician explaining why the drug is clinically necessary.
• Evidence that alternative (formulary) drugs are not appropriate for you.

Special authorization submission. If special authorization was not submitted, ask your physician to submit the form immediately. Insurers typically process special authorization decisions within 5–15 business days.

OLHI. For individual drug plan disputes, the OmbudService for Life & Health Insurance (OLHI) at olhi.ca provides free independent review. For group plan disputes, OLHI's scope is more limited.

Employer HR escalation. For group benefit plan denials, involve your HR team. HR has direct access to the insurer's group account manager.

Practical Steps for Canadians Denied Drug Coverage

• Ask your pharmacist first. Pharmacists are often familiar with plan formulary issues and special authorization requirements. They can initiate or assist with the special authorization process.
• Check CADTH listings. The Canadian Drug and Health Technology website publishes federal drug review recommendations. If your drug has received a positive CADTH recommendation, include this in your appeal.
• Contact the drug manufacturer. Many pharmaceutical companies have patient access programs that provide drugs at no cost or reduced cost while insurance appeals are ongoing. Ask your prescribing physician about manufacturer assistance programs.
• Quebec residents: check mandatory coverage. Quebec's mandatory drug insurance means your employer plan should cover drugs covered by RAMQ, and RAMQ should cover drugs not covered by your employer plan. If there is a gap between the two, this may be a coverage design error.
• Keep all pharmacy receipts. If you are paying out-of-pocket while an appeal is pending, keep receipts. If your appeal succeeds, you can claim reimbursement retroactively.

A drug coverage denial does not have to be permanent. With the right clinical documentation and a persistent appeal, many Canadians obtain coverage for the medications they need.

Fight Back With ClaimBack

ClaimBack's free AI tool drafts a professional appeal letter in minutes, tailored to your insurer and denial reason. Don't let a denial be the final word.

Fight your denial at ClaimBack →

Related Reading:

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal